GALVmed Chief Executive Dr Carolin Schumacher attended the International Veterinary Vaccinology Network (IVVN) Early Career Researcher Event,  held in Edinburgh, Scotland from 20-24 March. The event provides a unique opportunity to bring together a cohort of early career researchers from high- and low-income countries for networking and skill development including how to develop an academic […]

Livestock, including small ruminants, are an important asset for millions of people in low and middle-income countries and are a source of protein, income and wealth. However, animal diseases account for great losses in the livestock sector and seriously hamper animal production and small-scale producers’ livelihoods. Numerous limitations hinder small ruminant production in the Global […]

Timely and effective marketing authorisation of veterinary medicines requires a combination of rigorous scientific evaluation and efficient management of procedures.  In line with GALVmed’s role in implementing the AgResults Foot and Mouth Disease (FMD) Vaccine Challenge Project in Eastern Africa, GALVmed has worked with the Secretariat of the East African Community (EAC) to support National […]

In 2021, GALVmed and Ceva Santé Animale launched PREVENT (PRomoting and Enabling Vaccination Efficiently, Now and Tomorrow), a 4-year initiative that aims to improve the efficiency and sustainability of small-scale poultry production in Sub-Saharan Africa. One of the key objectives of this project is not only to boost poultry productivity but to bring a pragmatic […]

Edinburgh, UK (March 16, 2022) – The Global Alliance for Livestock Veterinary Medicines (GALVmed) has partnered with Elanco Animal Health to launch a new initiative to manage ticks and tick-borne diseases in Africa. MAHABA (Managing Animal Health and Acaricides for a Better Africa) aims to support small-scale producers in Nigeria and Uganda by defining and […]

At the occasion of the first Newsletter of the year, please receive my heartfelt wishes for a distinctively healthy, happy and prosperous New Year. I sincerely hope that the epidemiological risk of SARS CoV-2 will continue to diminish with increasing progress in public health management, GALVmed very much welcomes the relaxation of restrictions announced by […]

Located in Pwani region to the east of Tanzania’s Dar es Salaam region, Mkuza farm is a family hatchery business which has been in operation for more than twenty years. When we visited the hatchery, employees were hard at work tending to various aspects of the business. The business mainly supplies day-old broiler and layer […]

TribeCo, GALVmed’s animal distribution partner in Ghana, recently took possession of six million doses of various poultry vaccines from veterinary health company Ceva Santé Animale. The consignment, which was delivered in early December 2021 is part of Tribecovet’s strategy to source livestock and poultry vaccines and medicines directly from manufacturers, to increase its profitability and […]

An open letter to G20 leaders from the Action for Animal Health coalition.   Even before the COVID-19 pandemic wreaked havoc on our lives, diseases from animals were causing 2.7 million human deaths a year. Over 75% of new human infectious diseases emerge from animals, with zoonotic diseases affecting over 2 billion people. Over the last decade, zoonotic diseases […]

  GALVmed is pleased to announce the appointment of Dr Johnson Ouma as the new Senior Director of Research & Development, effective October 11, 2021. Dr Ouma is a Kenyan research & development professional with over 25 years’ experience in animal health and agricultural research & product development.  He joins GALVmed from the Africa Technical […]